G protein-coupled receptors (GPCRs) are important regulators of cellular signaling functions and therefore are a major target for drug discovery. The CB cannabinoid receptor is among the most highly expressed GPCRs in neurons, where it regulates many differentiated neuronal functions. One model system for studying the biochemistry of neuronal responses is the use of neuroblastoma cells originating from the C1300 tumor in the A/J mouse, including cloned cell lines NS20, N2A, N18TG2, N4TG1, and N1E-115, and various immortalized hybrids of neurons with N18TG2 cells. GPCR signal transduction is mediated through interaction with multiple types and subtypes of G proteins that transduce the receptor stimulus to effectors. The [S]GTPɣS assay provides a valuable pharmacological method to evaluate efficacy and potency in the first step in GPCR signaling. Here, we present detailed protocols for the [S]GTPɣS-binding assay to measure the total G protein binding and the antibody-targeted scintillation proximity assay to measure specific Gα proteins in neuroblastoma cell membrane preparations. This chapter presents step-by-step methods from cell culture, membrane preparation, assay procedures, and data analysis.
Proc Natl Acad Sci U S A. 1985 May;82(10):3499-503
[PMID:
3858835]
Curr Protoc Neurosci. 2005 Feb;Chapter 7:Unit 7.15
[PMID:
18428624]
Biochem Pharmacol. 2012 Jan 15;83(2):260-8
[PMID:
22093909]
Biol Rev Camb Philos Soc. 1975 May;50(2):129-65
[PMID:
240451]
Eur J Pharmacol. 2011 Jun 1;659(2-3):161-8
[PMID:
21458448]
Life Sci. 1995;56(23-24):1983-9
[PMID:
7776822]
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5780-5
[PMID:
10318961]
Neuropharmacology. 2001;40(2):221-32
[PMID:
11114401]
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3474-7
[PMID:
4530316]
Science. 1983 Nov 18;222(4625):794-9
[PMID:
6314503]
Life Sci. 2005 Aug 19;77(14):1522-30
[PMID:
15953619]
Cell Signal. 2013 Aug;25(8):1665-77
[PMID:
23571270]
Brain Res Mol Brain Res. 1998 Jan;53(1-2):163-73
[PMID:
9473654]
Proc Natl Acad Sci U S A. 1969 Sep;64(1):311-5
[PMID:
5263016]
Front Pharmacol. 2016 Nov 04;7:415
[PMID:
27867358]
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19144-9
[PMID:
16365309]
Mol Pharmacol. 1979 Jan;15(1):78-85
[PMID:
34092]
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):422-31
[PMID:
19839935]
Trends Pharmacol Sci. 2003 Feb;24(2):87-90
[PMID:
12559773]
J Biol Chem. 1982 Feb 10;257(3):1274-81
[PMID:
6276378]
Proc Natl Acad Sci U S A. 1970 May;66(1):160-7
[PMID:
5273894]
J Neurochem. 1977 Jul;29(1):141-50
[PMID:
18554]
Eur J Cancer (1965). 1977 Dec;13(12):1417-20
[PMID:
598387]
Biochem Pharmacol. 1997 Dec 1;54(11):1267-70
[PMID:
9416978]
Mol Pharmacol. 1993 Sep;44(3):498-503
[PMID:
8371711]
Anal Biochem. 1976 May 7;72:248-54
[PMID:
942051]
Neuropsychopharmacology. 2014 Jul;39(8):1833-42
[PMID:
24513972]
Mol Pharmacol. 1993 Jul;44(1):115-23
[PMID:
8341267]
J Pharmacol Exp Ther. 1998 May;285(2):553-60
[PMID:
9580597]
J Neurochem. 1987 May;48(5):1624-31
[PMID:
2435852]
Br J Pharmacol. 2004 Aug;142(8):1209-18
[PMID:
15308578]
Eur J Pharmacol. 1983 May 20;90(1):121-3
[PMID:
6873174]
Dev Biol. 1971 Aug;25(4):514-46
[PMID:
5166556]
Proc Natl Acad Sci U S A. 1979 Jul;76(7):3251-5
[PMID:
226964]
Biochem Pharmacol. 1978;27(8):1173-7
[PMID:
29648]
J Biol Chem. 1972 May 25;247(10):3159-69
[PMID:
5027747]
Neurosci Lett. 2012 Feb 6;508(2):67-72
[PMID:
22206832]
Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S60-5
[PMID:
18336996]
Br J Pharmacol. 2010 Nov;161(6):1238-49
[PMID:
20662841]
Mol Pharmacol. 1986 Mar;29(3):307-13
[PMID:
2869405]
J Neurosci Res. 2001 May 1;64(3):302-10
[PMID:
11319775]
Mol Pharmacol. 1998 Mar;53(3):504-10
[PMID:
9495818]
J Neurochem. 1978 Jun;30(6):1343-55
[PMID:
670976]
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3019-23
[PMID:
8385355]
Eur J Pharmacol. 1996 Jun 20;307(1):97-105
[PMID:
8831110]
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):311-22
[PMID:
27089415]
Br J Pharmacol. 2008 Jan;153(2):380-9
[PMID:
17965731]
J Pharmacol Exp Ther. 1999 May;289(2):946-55
[PMID:
10215674]
J Neurochem. 1986 Jun;46(6):1929-35
[PMID:
3009717]
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1314-8
[PMID:
206894]
Neuroreport. 2002 Apr 16;13(5):593-6
[PMID:
11973452]
Int Rev Cytol. 1977;49:99-170
[PMID:
16829]
Science. 1976 May 28;192(4242):907-8
[PMID:
1273576]
Pharmacol Rev. 2002 Jun;54(2):161-202
[PMID:
12037135]
In Vitro. 1979 Oct;15(10):807-12
[PMID:
42611]
J Neurosci. 2008 Nov 5;28(45):11593-602
[PMID:
18987195]
Anal Biochem. 1985 Oct;150(1):76-85
[PMID:
3843705]
J Neurochem. 1978 Sep;31(3):699-705
[PMID:
28385]
Cell Differ. 1978 Aug;7(4):193-201
[PMID:
699052]
Arch Biochem Biophys. 1977 May;181(1):103-16
[PMID:
195528]
Brain Res. 2006 Jun 6;1093(1):20-4
[PMID:
16684513]
Peptides. 1985 Nov-Dec;6(6):1075-8
[PMID:
3010255]
Adv Biochem Psychopharmacol. 1982;33:243-50
[PMID:
7124500]
Proc Natl Acad Sci U S A. 1970 Oct;67(2):786-92
[PMID:
5289021]
Mol Pharmacol. 1995 Apr;47(4):848-54
[PMID:
7723747]
Cell Signal. 2015 Mar;27(3):716-726
[PMID:
25446256]
Proc Natl Acad Sci U S A. 1969 Sep;64(1):316-23
[PMID:
4189500]
J Biol Chem. 1973 Oct 10;248(19):6610-7
[PMID:
4355495]
Mol Pharmacol. 2000 Jan;57(1):162-70
[PMID:
10617691]
Dev Dyn. 1992 Jul;194(3):209-21
[PMID:
1467557]
Biochim Biophys Acta. 1978 Apr 3;539(4):459-69
[PMID:
205271]
Brain Res. 1991 Jun 21;552(1):67-76
[PMID:
1913182]
